Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Antunac Golubić, Zrna"'
Autor:
Ladenhauser, Tatjana, Golčić, Marin, Urch, Kristina, Budisavljević, Anuška, Simetić, Luka, Kovač Peić, Anamarija, Dilber, Ivo, Antunac Golubić, Zrna, Blažičević, Krešo, Curić, Zvonimir, Nalbani, Mario, Belić, Dino, Radmilović Varga, Ljubica, Mirčevski, K, Jović Zlatović, Josipa, Kocić, Lidija, Pleština, Stjepko
Terapija imunim checkpoint inhibitorima (ICI) odobrena je od strane Hrvatskog zavoda za zdravstveno osiguranje (HZZO) godine 2017. te se od tada oni koriste za sve više malignih sijela. Unatoč velikim stečenim iskustvima u primjeni, do sada još n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::8a36fe41ffbbcd06430261c286c6dab7
https://www.bib.irb.hr/1237001
https://www.bib.irb.hr/1237001
Autor:
Antunac Golubić, Zrna
Uvod: Istraživanja su pokazala da više koncentracije 25(OH)D u krvi smanjuju rizik za pojavu raka debelog crijeva. Bolesnici s metastatskim rakom debelog crijeva imaju često insuficijenciju D vitamina, ali utjecaj vitamina D na prognozu bolesti je
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4137::4929aa979778ac3c0305dc4117291176
https://urn.nsk.hr/urn:nbn:hr:105:060470
https://urn.nsk.hr/urn:nbn:hr:105:060470
Razvoj metastatskog kastracijski refraktornog raka prostate kod većine bolesnika dovodi do smrti. Samim time je izazov za liječnika. U posljednjih deset godina dogodio se značajan napredak u razvoju lijekova za metastatski rak prostate. Učinkovit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::d7ec59e8642db36e3df6c3c891c479b3
https://www.bib.irb.hr/1263428
https://www.bib.irb.hr/1263428
Autor:
Antunac Golubić, Zrna
Broj bolesnika s malignim bolestima je u porastu, a s time rastu i komplikacije liječenja. Zbog toga su potrebni uređaji koji će omogućiti brzu i pouzdanu dijagnostiku hematološkoh parametara.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::a726f0ed910d4ec2c4865101d3893ee8
https://www.bib.irb.hr/1263426
https://www.bib.irb.hr/1263426
Autor:
Koši Kunac A; Zagreb University Hospital Centre, Department of Oncology, Division of Medical Oncology, Unit of Uro-oncology, Referral Center for Treatment of Germ Cell Tumors and Extragonadal Germ Cell Tumors of the Ministry of Health of the Republic of Croatia, Zagreb, Croatia., Gnjidić M; Zagreb University Hospital Centre, Department of Oncology, Division of Medical Oncology, Unit of Uro-oncology, Referral Center for Treatment of Germ Cell Tumors and Extragonadal Germ Cell Tumors of the Ministry of Health of the Republic of Croatia, Zagreb, Croatia., Antunac Golubić Z; Zagreb University Hospital Centre, Department of Oncology, Division of Medical Oncology, Unit of Uro-oncology, Referral Center for Treatment of Germ Cell Tumors and Extragonadal Germ Cell Tumors of the Ministry of Health of the Republic of Croatia, Zagreb, Croatia., Gamulin M; Zagreb University Hospital Centre, Department of Oncology, Division of Medical Oncology, Unit of Uro-oncology, Referral Center for Treatment of Germ Cell Tumors and Extragonadal Germ Cell Tumors of the Ministry of Health of the Republic of Croatia, Zagreb, Croatia.
Publikováno v:
Acta clinica Croatica [Acta Clin Croat] 2020 Sep; Vol. 59 (3), pp. 496-504.
Autor:
Gamulin M, Nham E, Rkman D, Antunac Golubić Z, Likić R; Robert Likic, University Hospital Centre Zagreb, Department of Internal Medicine Unit of Clinical Pharmacology, Kispaticeva 12, 10000 Zagreb, Croatia, robert.likic@mef.hr.
Publikováno v:
Croatian medical journal [Croat Med J] 2020 Aug 31; Vol. 61 (4), pp. 326-332.